Dr. Fouladi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
700 Childrens Dr
Columbus, OH 43205Phone+1 614-722-2000Fax+1 614-722-3369
Education & Training
- University of Toronto Faculty of MedicineClass of 1991
Certifications & Licensure
- OH State Medical License 2008 - 2027
- TN State Medical License 1998 - 2008
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- ACTEMRA® for the Treatment of Pediatric Adamantinomatous Craniopharyngioma Start of enrollment: 2022 Dec 16
Roles: Contact, Principal Investigator
- MEKTOVI® for the Treatment of Pediatric Adamantinomatous Craniopharyngioma Start of enrollment: 2023 Apr 10
Roles: Principal Investigator, Contact
- A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion Start of enrollment: 2021 Apr 08
Roles: Contact, Study Chair, Principal Investigator
- Join now to see all
Publications & Presentations
PubMed
- Central nervous system tumors in adolescents and young adults: A Society for Neuro-Oncology Consensus Review on diagnosis, management, and future directions.Mary Jane Lim-Fat, Julie Bennett, Quinn Ostrom, Mehdi Touat, Enrico Franceschi
Neuro-Oncology. 2025-01-12 - Molecular Testing for the World Health Organization Classification of Central Nervous System Tumors: A Review.Craig Horbinski, David A Solomon, Rimas V Lukas, Roger J Packer, Priscilla Brastianos
JAMA Oncology. 2024-12-26 - 1 citationsComments and Controversies in Oncology: The Tribulations of Trials Developing ONC201.Jordan R Hansford, Gauthier Bouche, Vijay Ramaswamy, Nada Jabado, Adriana Fonseca
Journal of Clinical Oncology. 2024-12-10
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: